Hillevax Net Worth

Hillevax Net Worth Breakdown

  HLVX
The net worth of Hillevax is the difference between its total assets and liabilities. Hillevax's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Hillevax's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Hillevax's net worth can be used as a measure of its financial health and stability which can help investors to decide if Hillevax is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Hillevax stock.

Hillevax Net Worth Analysis

Hillevax's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Hillevax's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Hillevax's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Hillevax's net worth analysis. One common approach is to calculate Hillevax's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Hillevax's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Hillevax's net worth. This approach calculates the present value of Hillevax's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Hillevax's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Hillevax's net worth. This involves comparing Hillevax's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Hillevax's net worth relative to its peers.

Enterprise Value

580.61 Million

To determine if Hillevax is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Hillevax's net worth research are outlined below:
Hillevax may become a speculative penny stock
Hillevax has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (123.57 M) with profit before overhead, payroll, taxes, and interest of 0.
Hillevax currently holds about 292.06 M in cash with (86.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.81, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Hillevax has a frail financial position based on the latest SEC disclosures
Over 75.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: HilleVax, Inc. Short Interest Update - MarketBeat
Hillevax uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Hillevax. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Hillevax's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
15th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Hillevax's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Hillevax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hillevax backward and forwards among themselves. Hillevax's institutional investor refers to the entity that pools money to purchase Hillevax's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
627.7 K
State Street Corp2024-06-30
595.4 K
Qiming U.s. Ventures Management, Llc2024-09-30
558.9 K
Millennium Management Llc2024-06-30
490 K
Trium Capital Llp2024-09-30
453.3 K
Deutsche Bank Ag2024-06-30
311.6 K
Northern Trust Corp2024-09-30
242.7 K
Catalys Pacific Llc2024-09-30
236.4 K
Citadel Advisors Llc2024-09-30
175.5 K
Tang Capital Management Llc2024-09-30
4.9 M
Blackrock Inc2024-06-30
2.1 M
Note, although Hillevax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Hillevax's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 96.62 M.

Market Cap

481.7 Million

Project Hillevax's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.36)(0.38)
Return On Capital Employed(0.42)(0.40)
Return On Assets(0.36)(0.38)
Return On Equity(0.47)(0.44)
When accessing Hillevax's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Hillevax's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Hillevax's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Hillevax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hillevax. Check Hillevax's Beneish M Score to see the likelihood of Hillevax's management manipulating its earnings.

Evaluate Hillevax's management efficiency

Hillevax has return on total asset (ROA) of (0.289) % which means that it has lost $0.289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6224) %, meaning that it created substantial loss on money invested by shareholders. Hillevax's management efficiency ratios could be used to measure how well Hillevax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.38 in 2024. Return On Capital Employed is likely to rise to -0.4 in 2024. At this time, Hillevax's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 2 M in 2024, whereas Total Assets are likely to drop slightly above 173.7 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 6.54  6.87 
Tangible Book Value Per Share 6.54  6.87 
Enterprise Value Over EBITDA(3.67)(3.85)
Price Book Value Ratio 2.45  2.58 
Enterprise Value Multiple(3.67)(3.85)
Price Fair Value 2.45  2.58 
Enterprise Value486.1 M580.6 M
The leadership approach at Hillevax's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Return On Equity
(0.62)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hillevax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hillevax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hillevax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Frazier Life Sciences X, L.p. over three weeks ago
Disposition of 2736234 shares by Frazier Life Sciences X, L.p. of Hillevax at 13.6 subject to Rule 16b-3
 
Gerberding Julie L. over three weeks ago
Disposition of tradable shares by Gerberding Julie L. of Hillevax subject to Rule 16b-3
 
Borkowski Astrid over a month ago
Disposition of 10000 shares by Borkowski Astrid of Hillevax at 14.2 subject to Rule 16b-3
 
Aditya Kohli over a month ago
Disposition of 8866 shares by Aditya Kohli of Hillevax at 14.9315 subject to Rule 16b-3
 
Borkowski Astrid over two months ago
Disposition of 10000 shares by Borkowski Astrid of Hillevax at 14.5 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.205 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 15.4482 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 723 shares by Aditya Kohli of Hillevax at 14.1542 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.0135 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.7075 subject to Rule 16b-3
 
Sean McLoughlin over six months ago
Acquisition by Sean McLoughlin of 1250 shares of Hillevax at 16.98 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 17.4153 subject to Rule 16b-3
Hillevax time-series forecasting models is one of many Hillevax's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hillevax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Hillevax Earnings per Share Projection vs Actual

Hillevax Corporate Management

Anju ChatterjiVP OperationsProfile
Kaia AgarwalVP AffairsProfile
Astrid MDChief OfficerProfile
Sean McLoughlinChief OfficerProfile
Paul JDSecretary CounselProfile
Ozzie BergerSenior AffairsProfile

Additional Tools for Hillevax Stock Analysis

When running Hillevax's price analysis, check to measure Hillevax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hillevax is operating at the current time. Most of Hillevax's value examination focuses on studying past and present price action to predict the probability of Hillevax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hillevax's price. Additionally, you may evaluate how the addition of Hillevax to your portfolios can decrease your overall portfolio volatility.